Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 11 tags : Phase 1 save search
Rafael Pharmaceuticals Announces First Patient Enrolled in APOLLO 613 Phase 1/2 Clinical Trial of CPI-613® (Devimistat) in Patients with Relapsed Clear Cell SarcomaNew Trial Sites Open at Cleveland Clinic Children’s and University of Michigan
Published: 2021-11-11 (Crawled : 15:00) - biospace.com/
RFL 4 | $1.76 2.92% 0.0% 26K
|
Finance
|
| O: 0.29%
H: 5.17%
C: 0.58%
phase 1 cpi-613 children trial enroll
Rafael Pharmaceuticals Announces First Patient Enrolled in APOLLO 613 Phase 1/2 Clinical Trial of CPI-613® (Devimistat) in Patients with Relapsed Clear Cell Sarcoma
Published: 2021-11-11 (Crawled : 14:15) - globenewswire.com
RFL 4 | $1.76 2.92% 0.0% 26K
|
Finance
|
| O: 0.29%
H: 5.17%
C: 0.58%
phase 1 cpi-613 trial enroll
Alkermes Announces First Subject Dosed in Phase 1 Study of ALKS 1140 for the Treatment of Neurodegenerative and Neurological Disorders
Published: 2021-11-11 (Crawled : 12:15) - prnewswire.com
ALKS | $23.86 0.42% 0.42% 2.4M
|
Health Technology
|
| O: -1.59%
H: 1.86%
C: -1.05%
treatment neurodegenerative neurological phase 1 phase 2
Dermata Announces Virtual Investor Event to Present DMT410 Phase 1b Proof of Concept Results in Aesthetic Skin Conditions
Published: 2021-11-11 (Crawled : 12:00) - biospace.com/
DRMA | $0.321 -5.09% -5.36% 28K
|
|
| O: -5.82%
H: 0.0%
C: 0.0%
phase 1 results aesthetic proof of concept phase 1b skin phase 2b
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.